Back to Search Start Over

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation

Authors :
Ginex, Tiziana
Marco-Marín, Clara
Wieczór, Miłosz
Mata, Carlos P.
Krieger, James
López-Redondo, Maria Luisa
Francés-Gómez, Clara
Ruiz-Rodriguez, Paula
Melero, Roberto
Sánchez-Sorzano, Carlos Óscar
Martínez, Marta
Gougeard, Nadine
Forcada-Nadal, Alicia
Zamora-Caballero, Sara
Gozalbo-Rovira, Roberto
Sanz-Frasquet, Carla
Bravo, Jeronimo
Rubio, Vicente
Marina, Alberto
Geller, Ron
Comas, Iñaki
Gil, Carmen
Coscolla, Mireia
Orozco, Modesto
Llácer, José Luis
Carazo, José-Maria
European Commission
Consejo Superior de Investigaciones Científicas (España)
Ministerio de Ciencia, Innovación y Universidades (España)
Agencia Estatal de Investigación (España)
Comunidad de Madrid
European Research Council
Instituto de Salud Carlos III
Banco Santander
Generalitat Valenciana
Ginex, Tiziana [0000-0002-5739-8713]
Marco-Marín, Clara [0000-0002-8813-3515]
Wieczor, Milosz [0000-0003-4990-8629]
Mata, Carlos P. [0000-0003-3381-7431]
Krieger, James [0000-0001-6194-6244]
López-Redondo, Marisa [0000-0002-3328-6821]
Francés-Gómez, Clara [0000-0001-7341-3824]
Ruiz-Rodríguez, Paula [0000-0003-0727-5974]
Melero, Roberto [0000-0001-9467-9381]
Sorzano, Carlos Óscar S. [0000-0002-9473-283X]
Martínez, Marta [0000-0002-8435-5540]
Gougeard, Nadine [0000-0001-7338-7267]
Forcada-Nadal, Alicia [0000-0003-0179-4044]
Zamora-Caballero, Sara [0000-0003-4717-8845]
Gozalbo-Rovira, Roberto [0000-0003-3427-3800]
Sanz-Frasquet, Carla [0000-0002-6990-3131]
Bravo, Jerónimo [0000-0001-6695-2846]
Rubio, Vicente [0000-0001-8124-1196]
Marina, Alberto [0000-0002-1334-5273]
Geller, Ron [0000-0002-7612-4611]
Comas, Iñaki [0000-0001-5504-9408]
Gil, Carmen [0000-0002-3882-6081]
Coscollá, Mireia [0000-0003-0752-0538]
Orozco, Modesto [0000-0002-8608-3278]
Llácer, José Luis [0000-0001-5304-1795]
Carazo, José M. [0000-0003-0788-8447]
Ginex, Tiziana
Marco-Marín, Clara
Wieczor, Milosz
Mata, Carlos P.
Krieger, James
López-Redondo, Marisa
Francés-Gómez, Clara
Ruiz-Rodríguez, Paula
Melero, Roberto
Sorzano, Carlos Óscar S.
Martínez, Marta
Gougeard, Nadine
Forcada-Nadal, Alicia
Zamora-Caballero, Sara
Gozalbo-Rovira, Roberto
Sanz-Frasquet, Carla
Bravo, Jerónimo
Rubio, Vicente
Marina, Alberto
Geller, Ron
Comas, Iñaki
Gil, Carmen
Coscollá, Mireia
Orozco, Modesto
Llácer, José Luis
Carazo, José M.
Source :
bioRxiv, Digital.CSIC. Repositorio Institucional del CSIC, instname

Abstract

The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness.<br />This research work was supported by the European Commission–NextGenerationEU through the CSIC Global Health Platform. Additionally, authors would like to acknowledge economic support from the Spanish Ministry of Science and Innovation through Grants: PID2019-104757RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, RTI2018-094399-A-I00, and “ERDF A way of making Europe”, by the “European Union”, Grant SEV 2017-0712 funded by MCIN/AEI /10.13039/501100011033, the “Comunidad Autónoma de Madrid" through Grant: S2017/BMD3817, and the European Union (EU) and Horizon 2020 through grants: Marie-Curie Fellowship EnLaCES (MSCA IF 2020, Proposal: 101024130) (to JK), HighResCells (ERC - 2018 - SyG, Proposal: 810057), and iNEXT-Discovery (Proposal: 871037). AM, VR, JB and JLL are funded by CIBERER-ISCIII (proposal: COV20/00437), Fondo Supera COVID-19 (proposal: CSICCOVID19-082), Banco Santander (Proposal: BlockAce), and CSIC PTI Salud Global (Proposal: 202080E110). VR is funded by the Spanish Ministry of Science and Innovation through Grant PID2020-120322RB-C21. IC is funded by project PID2019-104477RB-100, Fondo COVID COV20/00140 and ERC CoG 101001038. MC is funded by the RyC program from the Spanish Ministry of Science and Innovation, the Generalitat Valenciana (SEJI/2019/011).

Details

Language :
English
Database :
OpenAIRE
Journal :
bioRxiv, Digital.CSIC. Repositorio Institucional del CSIC, instname
Accession number :
edsair.doi.dedup.....26cc9d2270f48e5d8cc8e2eb1bc271e4
Full Text :
https://doi.org/10.1101/2021.12.05.471263